Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-trace').style.display = (document.getElementById('cakeErr680460ecb1cbc-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680460ecb1cbc-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-code').style.display = (document.getElementById('cakeErr680460ecb1cbc-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-context').style.display = (document.getElementById('cakeErr680460ecb1cbc-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680460ecb1cbc-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680460ecb1cbc-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;. </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20592, 'metaTitle' => 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee', 'metaKeywords' => 'medicines,Health', 'metaDesc' => ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...', 'disp' => '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;.</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;.</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;.</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;. </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20592 $metaTitle = 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee' $metaKeywords = 'medicines,Health' $metaDesc = ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...' $disp = '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;.</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;.</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;.</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee | Im4change.org</title> <meta name="description" content=" -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>House panel: Government clearing harmful drugs -Rupali Mukherjee</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine".</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine".</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people".</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-trace').style.display = (document.getElementById('cakeErr680460ecb1cbc-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680460ecb1cbc-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-code').style.display = (document.getElementById('cakeErr680460ecb1cbc-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-context').style.display = (document.getElementById('cakeErr680460ecb1cbc-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680460ecb1cbc-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680460ecb1cbc-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;. </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20592, 'metaTitle' => 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee', 'metaKeywords' => 'medicines,Health', 'metaDesc' => ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...', 'disp' => '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;.</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;.</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;.</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;. </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20592 $metaTitle = 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee' $metaKeywords = 'medicines,Health' $metaDesc = ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...' $disp = '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;.</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;.</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;.</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee | Im4change.org</title> <meta name="description" content=" -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>House panel: Government clearing harmful drugs -Rupali Mukherjee</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine".</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine".</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people".</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-trace').style.display = (document.getElementById('cakeErr680460ecb1cbc-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680460ecb1cbc-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-code').style.display = (document.getElementById('cakeErr680460ecb1cbc-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680460ecb1cbc-context').style.display = (document.getElementById('cakeErr680460ecb1cbc-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680460ecb1cbc-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680460ecb1cbc-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;. </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20592, 'metaTitle' => 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee', 'metaKeywords' => 'medicines,Health', 'metaDesc' => ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...', 'disp' => '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;.</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;.</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;.</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;. </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;. </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20592 $metaTitle = 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee' $metaKeywords = 'medicines,Health' $metaDesc = ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...' $disp = '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with &quot;dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's &quot;collusion with the intention to save the guilty''. The committee asked the government &quot;to follow global best practice in at least two burning cases-analgin and buclizine&quot;.</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should &quot;apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine&quot;.</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that &quot;the continued marketing of analgin, discarded the world over, is a matter of grave concern&quot; and putting analgin under so-called &quot;focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has &quot;failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says &quot;this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people&quot;.</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee | Im4change.org</title> <meta name="description" content=" -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>House panel: Government clearing harmful drugs -Rupali Mukherjee</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine".</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine".</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people".</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine". </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine". </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people". </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20592, 'metaTitle' => 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee', 'metaKeywords' => 'medicines,Health', 'metaDesc' => ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...', 'disp' => '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine".</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine".</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people".</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20592, 'title' => 'House panel: Government clearing harmful drugs -Rupali Mukherjee', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> <p align="justify"> <br /> <em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday. </p> <p align="justify"> Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine". </p> <p align="justify"> In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine". </p> <p align="justify"> The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic. </p> <p align="justify"> Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. </p> <p align="justify"> The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. </p> <p align="justify"> In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people". </p> <p align="justify"> In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. </p> <p align="justify"> However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>', 'credit_writer' => 'The Times of India, 27 April, 2013, http://timesofindia.indiatimes.com/india/House-panel-Government-clearing-harmful-drugs/articleshow/19749593.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'house-panel-government-clearing-harmful-drugs-rupali-mukherjee-20734', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20734, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20592 $metaTitle = 'LATEST NEWS UPDATES | House panel: Government clearing harmful drugs -Rupali Mukherjee' $metaKeywords = 'medicines,Health' $metaDesc = ' -The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a...' $disp = '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing to stop the marketing of 33 drugs which were approved without clinical trials. The ministry failed to issue orders to stop the marketing of these 33 drugs even after a span of seven months of the matter coming to light, and in most cases it failed to take any decisive action in the interest of patients, the committee said in its 66th report tabled in the Rajya Sabha on Friday.</p><p align="justify">Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine".</p><p align="justify">In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine".</p><p align="justify">The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic.</p><p align="justify">Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse.</p><p align="justify">The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry.</p><p align="justify">In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people".</p><p align="justify">In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee.</p><p align="justify">However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
House panel: Government clearing harmful drugs -Rupali Mukherjee |
-The Times of India
Hitting out at the appointment of a plethora of committees to stall decisions, it also pointed to the ministry's "collusion with the intention to save the guilty''. The committee asked the government "to follow global best practice in at least two burning cases-analgin and buclizine". In a rebuttal of the action taken by the government on the functioning of the Central Drugs Standard Control Organization ( CDSCO)-which approves all drugs in the country-based on the recommendations of the 59th parliamentary report submitted in May last year, the committee has said the ministry should "apply, albeit belatedly, this global best practice immediately in two burning cases-analgin and buclizine". The government, in its action taken report submitted in December last year, had said that it would suspend marketing approval of all drugs prohibited for sale in other countries like the US, the UK and Australia besides the EU. The committee noted in the report that "the continued marketing of analgin, discarded the world over, is a matter of grave concern" and putting analgin under so-called "focused pharmacovigilance'' is nothing but a diversionary tactic. Also, in another drug, buclizine, administered to children as an appetite improver, the report says that ministry has "failed to act on a proven case of gross illegality'' by referring it to a review committee. It asked the government to review the approval given on the drug. In the case of letrozole (innovator Novartis) too, the committee said that the ministry has failed to take action in this very open-and-shut case of impropriety and criminal lapse. The 66th report reviews the action taken by the government on the 59th report tabled last year in May on the functioning of the drug controller's office in the health ministry. In the case of 39 drugs approved without clinical trials and certain harmful fixed dose combinations, the committee has dismissed the government's reply, questioning why even after several months, these drugs continue to be marketed with impunity. It says "this inaction has led to unhindered marketing of these drugs with unknown and unspecified risks to unsuspecting people". In the case of 33-odd new drugs approved between 2008 and 2010 without conducting clinical trials on Indian patients, the committee said nothing concrete has been done even after a lapse of more than seven months, and the government plans to refer it to yet another committee. However, the committee has appreciated the government's efforts in examining applications for new drugs including fixed dose combinations. |